Telomir Pharmaceuticals Inc

NAS:TELO (USA)  
$ 4.90 -0.04 (-0.81%) 04:00 PM EST
At Loss
P/B:
98.00
Market Cap:
$ 145.09M
Enterprise V:
$ 146.37M
Volume:
34.17K
Avg Vol (2M):
178.57K
Trade In:
Volume:
34.17K
At Loss
Avg Vol (2M):
178.57K

Business Description

Telomir Pharmaceuticals Inc
NAICS : 541713 SIC : 2834
ISIN : US87975F1049
Compare
Compare
Traded in other countries / regions
TELO.USA
IPO Date
2024-02-09
Description
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
Name Current Vs Industry Vs History
Cash-To-Debt 18.65
Equity-to-Asset 0.75
Debt-to-Equity 0.06
Debt-to-EBITDA -0.01
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 37.11
9-Day RSI 38.03
14-Day RSI 42.11
6-1 Month Momentum % -31.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.94
Quick Ratio 3.94
Cash Ratio 3.53

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -4.21
Name Current Vs Industry Vs History
ROE % -665.08
ROA % -433.44
ROIC % -94.72
ROCE % -457.24

Financials (Next Earnings Date:2024-11-29 Est.)

TELO's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:TELO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Telomir Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.653
Beta 0
Volatility % 0
14-Day RSI 42.11
14-Day ATR ($) 0.54291
20-Day SMA ($) 5.937
12-1 Month Momentum % 0
52-Week Range ($) 3.11 - 20.72
Shares Outstanding (Mil) 29.61

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Telomir Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Telomir Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Telomir Pharmaceuticals Inc Frequently Asked Questions

What is Telomir Pharmaceuticals Inc(TELO)'s stock price today?
The current price of TELO is $4.90. The 52 week high of TELO is $20.72 and 52 week low is $3.11.
When is next earnings date of Telomir Pharmaceuticals Inc(TELO)?
The next earnings date of Telomir Pharmaceuticals Inc(TELO) is 2024-11-29 Est..
Does Telomir Pharmaceuticals Inc(TELO) pay dividends? If so, how much?
Telomir Pharmaceuticals Inc(TELO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1